Takeda Pharmaceutical (TAK) earnings per share (EPS)

Earnings per share · fiscal 2026
¥59.82

Takeda Pharmaceutical (TAK) reported diluted earnings per share of ¥59.82 in fiscal 2026 (the year ended March 31, 2026). That is 78.0% higher than the ¥33.62 of fiscal 2025. Figures as of 17 Nov 2026, 21:38 UTC, from Yahoo Finance.

Key facts

Earnings per share, fiscal 2026
¥59.82
Change on fiscal 2025
+78.0%
Highest on record
¥100.97fiscal 2023
Lowest on record
¥33.62fiscal 2025
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in JPY. Figures, not advice.

Takeda Pharmaceutical earnings per share (EPS), in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ¥100.97 in fiscal 2023 and the lowest ¥33.62 in fiscal 2025.

History · 4 fiscal years

Earnings per share by fiscal year

Takeda Pharmaceutical earnings per share (EPS), year by year

Takeda Pharmaceutical (TAK) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2026¥59.82 78.0% up
2025¥33.62 26.3% down
2024¥45.58 54.9% down
2023¥100.97—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Takeda Pharmaceutical and comparable companies
CompanyEarnings per shareFiscal year
Takeda Pharmaceutical TAK¥59.822026
Cencora COR$7.962025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical earnings per share (EPS): questions and answers

What is Takeda Pharmaceutical's diluted earnings per share?

Takeda Pharmaceutical (TAK) reported diluted earnings per share of ¥59.82 in fiscal 2026 (the year ended March 31, 2026). That is 78.0% higher than the ¥33.62 of fiscal 2025.

What are the highest and lowest diluted earnings per share figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was ¥100.97 in fiscal 2023 and the lowest ¥33.62 in fiscal 2025.

How is Takeda Pharmaceutical's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/TAK/eps

Underlying data: Yahoo Finance.